Table 1. Expression of TACE mRNA in HNSCC and TIMP3 mRNA in stromal tissues in relation to clinicopathological parameters.
Clinicopathological feature | n | TACElo | TACEhi | P-value | n | TIMP3STRlo | TIMP3STRhi | P-value |
---|---|---|---|---|---|---|---|---|
Quantification | ISH | ISH | ||||||
Age | ||||||||
⩽60 years | 50 | 38 | 12 | >0.5 | 50 | 35 | 15 | 0.312 |
>60 years | 55 | 44 | 11 | 56 | 44 | 12 | ||
Sex | ||||||||
Male | 69 | 53 | 16 | >0.5 | 71 | 51 | 20 | 0.364 |
Female | 36 | 29 | 7 | 35 | 28 | 7 | ||
Nodal status | ||||||||
LN− | 61 | 53 | 8 | 0.009 | 61 | 47 | 14 | >0.5 |
LN+ | 30 | 19 | 11 | 31 | 22 | 9 | ||
Tumour stage | ||||||||
T1 | 39 | 61 | 12 | 0.019 | 39 | 60 | 13 | 0.031 |
T2 | 34 | 34 | ||||||
T3 | 8 | 18 | 11 | 8 | 18 | 11 | ||
T4 | 21 | 21 | ||||||
Histological grading | ||||||||
G1 | 13 | 64 | 17 | >0.5 | 13 | 62 | 19 | >0.5 |
G2 | 68 | 68 | ||||||
G3 | 24 | 18 | 6 | 24 | 17 | 7 | ||
TIMP3 (ISH) | ||||||||
TIMP3STRlo | 77 | 64 | 13 | 0.022 | ||||
TIMP3STRhi | 26 | 16 | 10 |
Abbreviations: HNSCC=squamous cell carcinoma of the head and neck; TACE=tumour necrosis factor (TNF)-α converting enzyme; LN=lymph node; TIMP3=tissue inhibitor of metalloproteinases 3; ISH=in situ hybridisation. Bold and italic entries indicate statistically significant values.